Update on the genetics of allergic diseases. Journal of Allergy and Clinical Immunology. 2025; 155(6):1738-1752.
Massively Parallel Analysis of Genotype-Dependent Enhancer Activity Among Atopic Dermatitis Genetic Risk Variants. . 2024.
Filaggrin loss-of-function variants are associated with atopic dermatitis phenotypes in a diverse, early-life prospective cohort. JCI Insight. 2024; 9(9).
Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome. BMC Genomics. 2024; 25(1):273.
Systematic identification of genotype-dependent enhancer variants in eosinophilic esophagitis. American Journal of Human Genetics. 2024; 111(2):280-294.
Multiancestral polygenic risk score for pediatric asthma. Journal of Allergy and Clinical Immunology. 2022; 150(5):1086-1096.
Epigenetic and transcriptional dysregulation in CD4+ T cells in patients with atopic dermatitis. PLoS Genetics. 2022; 18(5):e1009973.
Epstein-Barr virus nuclear antigen 2 extensively rewires the human chromatin landscape at autoimmune risk loci. Genome Research. 2021; 31(12):2185-2198.
Runx1 shapes the chromatin landscape via a cascade of direct and indirect targets. PLoS Genetics. 2021; 17(6):e1009574.
Global discovery of lupus genetic risk variant allelic enhancer activity. Nature Communications. 2021; 12(1):1611.
Global discovery of lupus genetic risk variant allelic enhancer activity. Nature Communications. 2021; 12(1).
Replication and meta-analyses nominate numerous eosinophilic esophagitis risk genes. Journal of Allergy and Clinical Immunology. 2021; 147(1):255-266.
Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nature Genetics. 2018; 50(5):699-707.
Genetic Associations with Gestational Duration and Spontaneous Preterm Birth. New England Journal of Medicine. 2017; 377(12):1156-1167.
Transancestral mapping and genetic load in systemic lupus erythematosus. Nature Communications. 2017; 8:16021.
Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nature Genetics. 2014; 46(8):895-900.
Massively parallel analysis of genotype-dependent enhancer activity among atopic dermatitis genetic risk variants. Journal of Allergy and Clinical Immunology. 2025; 156(6):1600-1613.
Genome-wide cross-trait analysis of heterogeneous outcomes in early life atopic dermatitis. Pediatric Allergy and Immunology. 2025; 36(12):e70253.
Genome-wide discovery of multiple sclerosis genetic risk variant allelic regulatory activity. G3: Genes, Genomes, Genetics. 2025; 15(11).
B-Cell Repertoire of Children With Atopic Dermatitis Exhibits Altered IgE Maturation Associated With Allergic Food Sensitization. Allergy. European Journal of Allergy and Clinical Immunology. 2025.
Allergen-specific mRNA-lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice. Journal of Clinical Investigation. 2025; 135(21).
Erythroid-specific, inducible CDAN1∆/∆ mouse model phenocopies congenital dyserythropoietic anemia type-la. Blood. 2025; 146(Supplement 1):186-186.
Single-cell transcriptional landscape of liver transplant rejection reveals tissue persistence of clonally expanded, treatment-resistant T cells. American Journal of Transplantation. 2025; 25(11):2345-2360.
Implementing integrated genomic risk assessments for breast cancer: lessons learned from the Electronic Medical Records and Genomics study. JAMIA Open. 2025; 8(5):ooaf113.
Human cytomegalovirus infection coopts chromatin organization to diminish TEAD1 transcription factor activity. eLife. 2025; 13.
Human cytomegalovirus infection coopts chromatin organization to diminish TEAD1 transcription factor activity. eLife. 2025; 13.
Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics. Pharmacotherapy. 2025; 45(8):476-485.
Phenome-wide association study identifies multiple traits associated with a polygenic risk score for colorectal cancer. Human Genomics. 2025; 19(1):77.
A survey of pathogenic involvement in non-communicable human diseases. Communications Medicine. 2025; 5(1):242.
Update on the genetics of allergic diseases. Journal of Allergy and Clinical Immunology. 2025; 155(6):1738-1752.
GDF10 promotes rodent cardiomyocyte maturation during the postnatal period. Journal of Molecular and Cellular Cardiology. 2025; 201:16-31.
Genome-wide meta-analysis identifies novel risk loci for uterine fibroids within and across multiple ancestry groups. Nature Communications. 2025; 16(1):2273.
Fusion-specific chromatin profiles mediate transcriptional heterogeneity in MLL-rearranged acute lymphoblastic leukemia. Blood advances. 2025; 9(4):856-861.
Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants. Science. 2025; 387(6734):eadp4753.
Risk factors affecting polygenic score performance across diverse cohorts. eLife. 2025; 12.
Silencing TET1 expression alters the epigenomic landscape and amplifies transcriptomic responses to allergen in airway epithelial cells. Environmental Epigenetics. 2025; 11(1):dvaf007.
Genome-wide epigenetic profiling and transcriptome analysis in pediatric Obstructive Sleep Apnea: A focus on Black female children. Heliyon. 2024; 10(23):e40830.
Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting. Journal of Allergy and Clinical Immunology. 2024; 154(4):882-892.
Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis. Arthritis & Rheumatology. 2024; 76(10):1566-1572.
Massively Parallel Analysis of Genotype-Dependent Enhancer Activity Among Atopic Dermatitis Genetic Risk Variants. . 2024.
A deep catalogue of protein-coding variation in 983,578 individuals. Nature. 2024; 631(8021):583-592.
Variant level heritability estimates of type 2 diabetes in African Americans. Scientific Reports. 2024; 14(1):14009.
Managing differential performance of polygenic risk scores across groups: Real-world experience of the eMERGE Network. American Journal of Human Genetics. 2024; 111(6):999-1005.
Macrophage memories of early-life injury drive neonatal nociceptive priming. Cell reports. 2024; 43(5):114129.
Filaggrin loss-of-function variants are associated with atopic dermatitis phenotypes in a diverse, early-life prospective cohort. JCI Insight. 2024; 9(9).
Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome. BMC Genomics. 2024; 25(1):273.
Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations. Nature Medicine. 2024; 30(2):480-487.
Systematic identification of genotype-dependent enhancer variants in eosinophilic esophagitis. American Journal of Human Genetics. 2024; 111(2):280-294.
The transcription factor ZEB2 drives the formation of age-associated B cells. Science. 2024; 383(6681):413-421.
Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting. Journal of Allergy and Clinical Immunology. 2023; 152(6):1382-1393.
Effector memory T cells induce innate inflammation by triggering DNA damage and a non-canonical STING pathway in dendritic cells. Cell reports. 2023; 42(10):113180.
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets. Nature Communications. 2023; 14(1):6030.
A functional mechanism for a non-coding variant near AGTR2 associated with risk for preterm birth. BMC Medicine. 2023; 21(1):258.
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. Nature Genetics. 2023; 55(7):1091-1105.
Utilization of electronic health record data to evaluate the association of urban environment with systemic lupus erythematosus symptoms. Rheumatology. 2023; 62(6):e180-e181.
Genome-wide admixture and association analysis identifies African ancestry-specific risk loci of eosinophilic esophagitis in African Americans. Journal of Allergy and Clinical Immunology. 2023; 151(5):1337-1350.
Returning integrated genomic risk and clinical recommendations: The eMERGE study. Genetics in Medicine. 2023; 25(4):100006.
A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth. Nature Communications. 2023; 14(1):1598.
Inference of Causal Relationships Between Genetic Risk Factors for Cardiometabolic Phenotypes and Female-Specific Health Conditions. Journal of the American Heart Association. 2023; 12(5):e026561.
Gene-environment interactions and their impact on human health. Genes and Immunity. 2023; 24(1):1-11.
Quantifying factors that affect polygenic risk score performance across diverse ancestries and age groups for body mass index. Pacific Symposium on Biocomputing. 2023; 28:437-448.
maxATAC: Genome-scale transcription-factor binding prediction from ATAC-seq with deep neural networks. PLoS Computational Biology. 2023; 19(1):e1010863.
Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure. Nature Communications. 2022; 13(1):6914.
Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits. Nature Communications. 2022; 13(1):6859.
Multiancestral polygenic risk score for pediatric asthma. Journal of Allergy and Clinical Immunology. 2022; 150(5):1086-1096.
Frontotemporal degeneration genetic risk loci and transcription regulation as a possible mechanistic link to disease risk. Medicine (United Kingdom). 2022; 101(41):e31078.
Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations. Genome Medicine. 2022; 14(1):70.
Epigenetic and transcriptional dysregulation in CD4+ T cells in patients with atopic dermatitis. PLoS Genetics. 2022; 18(5):e1009973.
Enrichment of Epstein Barr Virus in patients with Multiple Sclerosis. Journal of Immunology. 2022; 208(Supplement_1):104.09-104.09.
Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery. Nature Communications. 2022; 13(1):1855.
Inference of causal relationships between genetic risk factors for cardiometabolic phenotypes and female-specific health conditions. Res Sq. 2022.
CASCADE: high-throughput characterization of regulatory complex binding altered by non-coding variants. Cell Genomics. 2022; 2(2).